RxDoctor Payments Data

Linda Sullivan, DO

Family Medicine · Seguin, TXNPI 1932425089

Payments from drug & device makers

$2,995in general payments, 2019–2025

Across 174 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$497
  • AstraZeneca$292
  • Novo Nordisk$279
  • GSK$250
  • Lilly USA, LLC$233
  • Pfizer$226
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,95699%
  • Education$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,995 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$69,597
Medicare patients
251
Services billed
982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide86$100,144
JardianceEmpagliflozin45$45,687
RybelsusSemaglutide22$41,184
EliquisApixaban46$39,184
MounjaroTirzepatide21$35,464
FarxigaDapagliflozin Propanediol22$28,879
TrulicityDulaglutide22$27,764
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$22,281
MyrbetriqMirabegron19$18,671
KerendiaFinerenone14$15,427
SynthroidLevothyroxine Sodium44$3,745
Atorvastatin Calcium238$3,228
Rosuvastatin Calcium180$3,199
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,625
Omeprazole120$2,395

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$279$141,328108 claims
Lilly USA, LLCMounjaro, Trulicity$233$63,22843 claims
Boehringer IngelheimJardiance$124$45,68745 claims
PfizerEliquis$226$39,18446 claims
AstraZenecaFarxiga$292$28,87922 claims
GSKTrelegy Ellipta$250$22,28131 claims
BayerKerendia$113$15,42714 claims
AbbVieSynthroid$497$3,74544 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Seguin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →